Letter: Low‐ FODMAP Diet in Irritable Bowel Syndrome—Beyond the Hype!
Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (3) · 420-421
DOI: 10.1111/apt.70792 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-06-12. Written by Mohamed G Shiha and 1 co-authors. Institution: Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK. Cited 1 times so far (Crossref); 9 references. The full text is freely available in PubMed Central.
Abstract (original language)
Ebda abstract disponibbli.
Authors and institutions
- Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
- Department of Gastroenterology, University Hospitals of Leicester, Leicester, UK.
- Department of Gastroenterology-Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands.
ORCID profiles: Mohamed G Shiha, Daniel Keszthelyi
Cite
APA
Shiha, M. G., & Keszthelyi, D. (2026). Letter: Low‐ FODMAP Diet in Irritable Bowel Syndrome—Beyond the Hype!. Alimentary Pharmacology & Therapeutics, 64(3), 420-421. https://doi.org/10.1111/apt.70792
Vancouver
Shiha MG, Keszthelyi D. Letter: Low‐ FODMAP Diet in Irritable Bowel Syndrome—Beyond the Hype!. Alimentary Pharmacology & Therapeutics. 2026;64(3):420-421. doi:10.1111/apt.70792
BibTeX
@article{Shiha2026,
author = {Shiha, Mohamed G and Keszthelyi, Daniel},
title = {Letter: Low‐ FODMAP Diet in Irritable Bowel Syndrome—Beyond the Hype!},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {3},
pages = {420--421},
doi = {10.1111/apt.70792}
}
EUVIMED